HomeMedicines › Reactin 50 Tablet

Reactin 50 Tablet

Diclofenac (50mg)

MRP (typical)
₹20.09 – ₹27.17
GST rate
5.0%
HSN
3004
Schedule
General
Pack
strip of 10 tablets
Manufacturer
Cipla Ltd

About Reactin 50 Tablet

Reactin 50 Tablet contains Diclofenac 50mg, which belongs to the class of non-steroidal anti-inflammatory drugs (NSAIDs). Diclofenac is available in various strengths including 25mg, 50mg, and 100mg formulations. This medicine is classified under General schedule and is subject to 5% GST in India under HSN code 3004. The product is supplied in a strip packaging containing 10 tablets.

Substitutes and alternatives

The following medicines contain the same active ingredient (Diclofenac (50mg)) and may be offered by pharmacists as substitutes. Actual substitute selection depends on availability at your pharmacy and prescribing doctor's instructions.

Godic Diclofenac Gel
MRP ₹59.0

Frequently asked

What is the GST rate and HSN code for Reactin 50 Tablet?

Reactin 50 Tablet is subject to 5% GST in India and falls under HSN code 3004, which covers medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses.

What schedule classification does Reactin 50 Tablet fall under?

Reactin 50 Tablet is classified under General schedule, meaning it can be sold without prescription but must be dispensed by a qualified pharmacist from a licensed pharmacy.

What are common brand variants containing Diclofenac 50mg in India?

Common Diclofenac 50mg brands in India may include Voveran, Diclowin, Diclonac, Dynapar, and Reactin. Brand availability may vary by region and manufacturer distribution.

Selling Reactin 50 Tablet at your pharmacy?

Nesayo tracks your stock, flags near-expiry, and auto-orders from your distributor when you run low.

Start free →

This page is informational only. Pricing and availability vary by pharmacy, location, and time. Verify current MRP on the printed package before sale. Consult a registered physician or pharmacist for medical advice. Nesayo is not a medical device and does not provide clinical decision support.